McCann Corey - Insider Non-Derivative Transactions at Pear Therapeutics, Inc. (PEAR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 20, 2023, McCann Corey's relationship to Pear Therapeutics, Inc. (PEAR) is Director,Officer (President and CEO), and currently has 8,245,565 shares of Common Stock, and 8,210,834 shares of Class A Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PEAR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

McCann Corey - Insider Non-Derivative Transactions of PEAR Common Stock

McCann Corey - Insider Non-Derivative Transactions of PEAR Class A Common Stock

McCann Corey - Insider Non-Derivative Transactions at PEAR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 21, 2023	Sell -- (Class A Common Stock)	34731	1.13	8210834
Jan 15, 2023	M -- (Common Stock)	88000	0	8245565